MedPath

Intervention by a Cardiologist and Geriatrician in Elderly Patients After Admission Due to Heart Failure.

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Other: Combined ambulatory visit
Other: Ambulatory visit
Other: Geriatric intervention
Registration Number
NCT03555318
Lead Sponsor
Parc de Salut Mar
Brief Summary

Randomized clinical trial in which patients with a recent admission for heart failure in the cardiology department of the Hospital de Mar will be randomized to usual follow-up (cardiologist of the Heart Failure Unit) or follow-up by cardiologist and intervention by the geriatrician. This visit will be done at the same time. The main gial of this study is to evaluate whether the combined intervention of a cardiologist and a geriatrician reduces hospital all-cause rehospitalizations at 1 year.

Detailed Description

Patients will be invited to participate on the day of hospital discharge. Once the informed consent has been signed, patients will be randomized with a 1: 1 ratio to conventional follow-up (cardiologist) or combined follow-up (ambulatory visit with cardiologist and geriatrics on the same day). Randomization will be stratified according to the presence or absence of criteria of frailty and ventricular function (cut-off 50%) to ensure that both groups are balanced. This stratification will be achieved by generating 4 different randomization lists. Frailty will be assessed using the Canadian Study of Health and Aging (CSHA) Clinical Frailty Scale. Randomization will be carried out by administrative staff independent of the study following a computer generated randomization scheme.The first visit will be made in less than 10 days after discharge from the hospital. Lawton and Barthel index and Pfeiffer test and quality of life test will be done in both groups.

The cost associated with care in the hospital is collected in each patient and therefore the total cost of the admissions, ambulatory visits and emergencies of each patient will be retrospectively evaluated.

In patients in the intervention arm the following areas will be evaluated: social sphere (Social and family evaluation scale of Gijón (abbreviated and modified) (Barcelona version), functional capacity (Barthel index and Lawton index), cognitive sphere (Pfeiffer test), emotional sphere (Geriatric Depression Scale Yesavage), nutritional status (Mini-Nutritional Assessment Short Form, plasma albumin), comorbidity (Charlson index) and the presence of geriatric syndromes (falls, polypharmacy, ulcers pressure, constipation, incontinence, insomnia.) Interdisciplinary interventions will be carried out in each of the areas evaluated.

Follow-up will be carried out at the heart failure clinic of the Cardiology Department at 3, 6 and 12 months. A clinical event evaluation committee will be appointed, consisting of 2 independent cardiologists, who will blindly adjudicate the events that occurred during the duration of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients older than 75 years with a recent admission for heart failure (within the previous 10 days).
Exclusion Criteria
  • Patients in palliative care.
  • Patients with chronic pathologies with expected life expectancy <1 year.
  • Patients discharged to a skilled nursing facility
  • Patients with heart valve replacement during index admission

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Geriatrician + CardiologistGeriatric interventionPatients randomized to a combined ambulatory follow up with a cardiologist and a geriatrician.
Geriatrician + CardiologistCombined ambulatory visitPatients randomized to a combined ambulatory follow up with a cardiologist and a geriatrician.
CardiologistAmbulatory visitPatients randomized to usual care (ambulatory follow up with a cardiologist).
Primary Outcome Measures
NameTimeMethod
Number of participants with all-cause hospitalization within the defined time points1 year

Number of participants with an all-cause hospitalization at 1 year follow-up

Secondary Outcome Measures
NameTimeMethod
Number of participants with heart failure hospitalization within the defined time points1 year

Number of participants with heart failure hospitalization at 1 year follow-up

Differences in total number of outpatient visits, emergency room visits and hospitalizations (resource use) within the defined time points1 year

Differences in total number of outpatient visits, emergency room visits and hospitalizations (resource use) at 1 year follow-up

Change in functional capacity measured with the Barthel index within the defined time points1 year

Change in functional capacity measured with the Barthel index at 1 year follow-up

Change in quality of life measured with the Kansas City Cardiomyopathy Questionnaire (KCCQ) within the defined time points1 year

Change in quality of life measured with the Kansas City Cardiomyopathy Questionnaire (KCCQ), a self-applicable health related quality of life instrument specific to heart failure, within the defined time points. The KCCQ ranges from 0 to 100, with 100 being the best state. A change in 5 points at 1 year follow-up will be considered clinically relevant.

Number of participants dead within the defined time points1 year

Number of participants dead at 1 year follow-up

Change in the number of participants with more than 5 medications (polypharmacy) within the defined time points1 year

Change in the number of participants with more than 5 medications (polypharmacy) at 1 year follow-up

Trial Locations

Locations (1)

Hospital del Mar, Parc de Salut Mar

🇪🇸

Barcelona, Non-USA, Spain

© Copyright 2025. All Rights Reserved by MedPath